Author Question: Which question has the highest priority when assessing a newly admitted patient with a history of ... (Read 95 times)

geoffrey

  • Hero Member
  • *****
  • Posts: 880
Which question has the highest priority when assessing a newly admitted patient with a history of alcohol abuse?
 
  a. Have you ever had blackouts?
  b. When did you have your last drink?
  c. Has drinking caused you any problems?
  d. When did you decide to seek treatment?

Question 2

A patient is admitted in a comatose state after ingesting 30 capsules of pentobarbital sodium. A friend of the patient says, Often my friend drinks, along with taking more of the drug than is ordered.
 
  What is the effect of the use of alcohol with this drug?
 
  a. The drug's metabolism is stimulated.
  b. The drug's effect is diminished.
  c. A synergistic effect occurs.
  d. There is no effect.



JaynaD87

  • Sr. Member
  • ****
  • Posts: 368
Answer to Question 1

ANS: B
Learning when the patient had the last drink is essential to knowing when to begin to observe for symptoms of withdrawal. The other questions are relevant but of lower priority.

Answer to Question 2

ANS: C
Both pentobarbital and alcohol are CNS depressants and have synergistic effects. Taken together, the action of each would potentiate the other.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

The top five reasons that children stay home from school are as follows: colds, stomach flu (gastroenteritis), ear infection (otitis media), pink eye (conjunctivitis), and sore throat.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library